Pritzker Private Capital has acquired KabaFusion.

Pritzker Private Capital has acquired KabaFusion, a provider of acute and specialty home infusion services. Financial terms were not disclosed. KabaFusion operates seven fully accredited specialty pharmacies located in more than 40 states, specializing in intravenous immunoglobulin (IVIG) and other infusion therapies. “We are committed to providing our patients with the highest quality of specialty home infusion treatments and are thrilled to partner with Pritzker Private Capital. We selected Pritzker Private Capital because of their deep experience in healthcare services and differentiated long-term approach to building world-class businesses.” Dr. Masood, KabaFusion’s CEO.